MesoTV Podcast: Conversations Impacting the Mesothelioma Community

A podcast by Mesothelioma Applied Research Foundation

39 Episodes

  1. MesoTV: The surgical approach to meso and how genetics impact treatment

    Published: 12/14/2021

  2. Radiation and immunotherapy: emerging mechanisms of synergy w/ Dr. Breen from Mayo Clinic

    Published: 11/9/2021

  3. Chemotherapy + immunotherapy, another positive step in mesothelioma treatment

    Published: 11/9/2021

  4. ”Does staging matter in mesothelioma” with Dr. James Stevenson of the Cleveland Clinic

    Published: 10/1/2021

  5. Pneumonitis in immunotherapy-treated mesothelioma patients

    Published: 9/30/2021

  6. Peritoneal mesothelioma surgery and treatment at the National Cancer Institute

    Published: 9/30/2021

  7. Toxicities, side-effects, from immunotherapy for treatment of mesothelioma

    Published: 7/13/2021

  8. CLINICAL TRIAL: Engineered T-cell therapy (TC-210, gavo-cel) for mesothelioma

    Published: 6/11/2021

  9. CLINICAL TRIAL: Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma

    Published: 5/25/2021

  10. Current trends in mesothelioma treatment - discussion by thought-leaders in this disease

    Published: 5/20/2021

  11. Pain management for mesothelioma patients from a multi-disciplinary perspective

    Published: 5/18/2021

  12. Discussion of mesothelioma patients who underwent an EPP (extrapleural pneumonectomy - lung removal)

    Published: 2/3/2021

  13. Clinical trial assessing the addition of IMRT to pemetrexed (Alimta)/platinum based therapy

    Published: 1/26/2021

  14. Vaccination Considerations for Mesothelioma Patients

    Published: 1/13/2021

  15. Dr. Paul Sugarbaker discusses HIPEC in peritoneal mesothelioma

    Published: 1/11/2021

  16. Mesothelioma Patients Discuss "Chemo Brain"

    Published: 1/7/2021

  17. Inherited Genetics and Mesothelioma

    Published: 1/6/2021

  18. Life After Mesothelioma Treatment Community Panel

    Published: 1/6/2021

  19. FDA's Expanded Access and Compassionate Use Rules' Impact on Mesothelioma Treatment

    Published: 1/6/2021

2 / 2

The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment, mesothelioma science, the patient and caregiver experience and quality of life. The Mesothelioma Applied Research Foundation is the only nonprofit charity organization dedicated to ending mesothelioma, and the suffering caused by this cancer, by: funding research to improve treatment options; providing treatment support and education for patients and their families; and advocating for federal funding of research.